Jump to ContentJump to Main Navigation

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R. / Tsongalis, Gregory J.

12 Issues per year

IMPACT FACTOR 2013: 2.955
Rank 5 out of 29 in category Medical Laboratory Technology in the 2013 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR): 0.860
Source Normalized Impact per Paper (SNIP): 1.046



“Coelionomics”: towards understanding the molecular pathology of coeliac disease

Begoña Diosdado1 / Erica van Oort2 / Cisca Wijmenga3




Corresponding author: Prof. Cisca Wijmenga, Complex Genetics Section, Department of Biomedical Genetics, Stratenum 2.117, University Medical Centre Utrecht, P.O. Box 85060 AT, 3508 AB Utrecht, The Netherlands Phone: +31-30 253 8427, Fax: +31-30 253 8479,

Citation Information: Clinical Chemical Laboratory Medicine. Volume 43, Issue 7, Pages 685–695, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2005.117, August 2005

Publication History

January 13, 2005
May 19, 2005
Published Online:


Coeliac disease (CD) is an inflammatory disorder of the small intestine characterised by a permanent intolerance to gluten-derived peptides. When gluten-derived peptides reach the lamina propria in CD patients, they provoke specific changes in the mucosa of their small intestine. Although the susceptibility to CD is strongly determined by environmental gluten, it is clearly a common genetic disorder. Important genetic factors for CD are the HLA-DQ genes located in the MHC region on chromosome 6 [ HLA-DQ2 (95%) or HLA-DQ8 (∼5%) heterodimers]. So far, the only treatment for CD consists of a life-long gluten-free diet. A key question in CD is why the gluten-derived peptides are resistant to further breakdown by endogenous proteases and how, in turn, they can activate a harmful immune response in the lamina propria of genetically predisposed individuals. Four mechanisms, namely apoptosis, oxidative stress, matrix metalloproteinases and dysregulation of proliferation and differentiation, are thought to play a role in the pathophysiology of CD. Whether the genes involved in these four mechanisms play a causative role in the development of the villous atrophy or are, in fact, a consequence of the disease process is unknown. In this review we summarise these mechanisms and discuss their validity in the context of current insights derived from genetic, genomic and molecular studies. We also discuss future directions for research and the therapeutic implications for patients.

Keywords: apoptosis; coeliac disease; matrix metalloproteinases; oxidative stress; proliferation and differentiation

Comments (0)

Please log in or register to comment.